In 2023, Brazil's import of Phenazone (Antipyrin) stood at 60 million USD. Looking at the forecasted data from 2024 to 2028, there is a steady annual increase in the import value. Specifically, imports are expected to grow from 61.067 million USD in 2024 to 65.815 million USD in 2028. The year-on-year percentage growth from 2024 to 2025 is 2.01%, maintaining a similar trend through 2028.

Over a five-year period (2024-2028), the compound annual growth rate (CAGR) is approximately 1.88%. This consistent upward trend suggests a stable increase in demand or usage of Phenazone in Brazil.

Future trends to watch for include:

Potential changes in regulatory policies affecting pharmaceutical imports.
Shifts in domestic production that could impact import volumes.
Market dynamics within the healthcare sector, particularly growth in segments utilizing Phenazone.